The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Methyl-4-(7-methoxy-1-methyl-beta-carbolin-9-yl)butyric Acid Methyl Ester ID: ALA4442374
PubChem CID: 155515881
Max Phase: Preclinical
Molecular Formula: C19H22N2O3
Molecular Weight: 326.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)C(C)CCn1c2cc(OC)ccc2c2ccnc(C)c21
Standard InChI: InChI=1S/C19H22N2O3/c1-12(19(22)24-4)8-10-21-17-11-14(23-3)5-6-15(17)16-7-9-20-13(2)18(16)21/h5-7,9,11-12H,8,10H2,1-4H3
Standard InChI Key: UKIATPGUBXMJLS-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
3.4613 -13.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4602 -14.2165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1682 -14.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1664 -12.9881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8751 -13.3933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8753 -14.2165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6583 -14.4707 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6579 -13.1388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1389 -13.8058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9551 -13.7219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2913 -12.9717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8052 -12.3045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9907 -12.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4338 -14.3842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7522 -14.6245 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0448 -14.2154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9119 -15.2476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3659 -15.8556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6194 -16.6324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0734 -17.2405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3270 -18.0173 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2739 -17.0716 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7810 -18.6253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4190 -16.8013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 9 1 0
8 5 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
10 14 1 0
2 15 1 0
15 16 1 0
7 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
19 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 326.40Molecular Weight (Monoisotopic): 326.1630AlogP: 3.71#Rotatable Bonds: 5Polar Surface Area: 53.35Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.11CX LogP: 2.76CX LogD: 2.74Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.67Np Likeness Score: 0.02
References 1. Kumar K, Wang P, Wilson J, Zlatanic V, Berrouet C, Khamrui S, Secor C, Swartz EA, Lazarus M, Sanchez R, Stewart AF, Garcia-Ocana A, DeVita RJ.. (2020) Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor., 63 (6): [PMID:32003560 ] [10.1021/acs.jmedchem.9b01379 ]